SentrX™ Leadership

Richard K. Koehn, Ph.D.
Co-founder, Chairman and Executive Director
A consultant to the venture capital business for over 15 years, Dr. Koehn was Entrepeneur of the Year in 1991. As CEO of Salus Therapeutics, he negotiated its acquisition by Genta, Inc. In 2005, Dr. Koehn negotiated a $7.5M investment in SentrX Surgical, Inc. leading to the creation of Carbylan BioSurgery, Inc.; Glycosan Biosystems, Inc.; and SentrX™ Animal Care, Inc. Founding Director of the Center for Advanced Biomedical Technology in NY, and Vice President of Research at the University of Utah (1992-2000), in 2005, Dr. Koehn was awarded the Governor's Medal in Science and Technology.

Brian Segebrecht, MBA
President & Chief Executive Officer
Mr. Segebrecht has over 6 years of experience in the animal health industry in acquisitions, divestitures, in-licensing transactions, corporate strategy and business planning. Prior to joining SentrX, Mr. Segebrecht worked for Bayer Animal Health where he held positions in R&D Project Management, Strategy and Business Development and Licensing. His industry knowledge and experience extends to production animal products and companion animal products; EPA-regulated and FDA-regulated products; and both over-the-counter and prescription products. Mr. Segebrecht holds a B.Sc. in Finance and M.B.A. from the University of Kansas. He also attended program for executives on Negotiations and Decision Making Strategies at the University of Chicago’s Booth School of Business.

Sarah K. Atzet, Ph.D.
Chief Operating Officer
B.Sc. (2002), Chemical Engineering, University of Utah; M.S. (2004), Chemical Engineering, University of Washington; Ph.D. (2008), Chemical Engineering, University of Washington. Dr. Atzet has considerable experience in the development and testing of biomaterials for medical applications. Prior to joining SentrX™ Animal Care, Inc., she was Director of Research & Development at Glycosan BioSystems, Inc. (Salt Lake City, UT). Dr. Atzet also holds an adjunct faculty position in the Department of Chemical Engineering at the University of Utah.

Glenn D. Prestwich, Ph.D.
Co-founder and Senior Scientific Advisor
Presidential Professor of Medicinal Chemistry, The University of Utah (1996-present); B.Sc. (1970), Chemistry, California Institute of Technology; Ph.D. (1974), Chemistry, Stanford University; Alfred P. Sloan Research and Dreyfus Teacher-Scholar Awards; 1998 Paul Dawson Biotechnology Award (AACP); Fellow of American Institute for Medical and Biological Engineering Professor of Chemistry, Stony Brook University (1977-1996); Director, Center for Biotechnology (Stony Brook, 1992-1996); Director, Center for Cell Signaling (2002-2007); Director, Center for Therapeutic Biomaterials (2004-present). Co-founder and former CSO, Eschelon Biosciences, Inc. (Salt Lake City, UT); Co-founder and former CSO, SentrX Surgical, Inc.; Senior Scientific Advisor, Carbylan BioSurgery, Inc. (Palo Alto, CA); Co-founder and former CSO, Glycosan Biosystems, Inc. (Salt Lake City, UT). Dr. Prestwich has published over 556 papers, patents, and book chapters; additionally, he has trained over 69 graduate students and 53 postdocs over the course of 30+ years.

© 2019 SentrX™ Animal Care, Inc. equitrX™, canitrX™, and felitrX™ are trademarks of SentrX™ Animal Care, Inc. All other trademarks are the sole property of their respective owners.